NOVO NORDISK
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity.
NOVO NORDISK
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
1923-01-01
Address:
Bagsværd, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.novonordisk.com
Total Employee:
10001+
Status:
Active
Contact:
+45 44 44 88 88
Total Funding:
22 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Apache Global Site Tag Nginx
Similar Organizations
Angelini Pharma
Angelini Pharma specializes in healthcare, with particular expertise in the fields of mental health, pain and inflammation, and pediatrics.
apomio
apomio is a German pharmacy and drug price comparison website that allows patients to submit adverse reactions and rate pharmacies.
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
BIOTRONIK
Biotronik is a privately held multinational biomedical technology company headquartered in Berlin, Germany.
Breas Medical
Breas Medical AB, a member of the GE Healthcare group, was founded in Gothenburg, Sweden in 1991 and has continued to expand during two
Desitin Arzneimittel
Desitin Arzneimittel is a European pharmaceutical company specializes in products for the therapy of neurological and psychiatric diseases.
Eu Yan Sang Singapore
Eu Yan Sang is Asia's leading integrative healthcare and wellness company with a strong foundation in Traditional Chinese medicine.
Laboratoires Genevrier
Laboratoires Genevrier engages in improving human health by offering an extensive range of innovative and effective pharmaceutical products.
Lacer
Lacer is a Spanish company with an international scope in human healthcare.
Me Cure
Me Cure is the fastest growing healthcare company in West Africa; we have medical imaging diagnostic centers in alliance with GE.
Okyo Pharma
Okyo Pharma focuses on novel GPCR based therapeutics for eye diseases of high unmet need and non-opioid analgesics for chronic pain.
PDP Couriers
PDP Couriers is a truly global specialist courier for clinical trials, transport of clinical and medical research and logistics management.
PharmaCord
PharmaCord is a healthcare company that provides innovative solutions that drive efficient and rapid access to life saving therapies.
Real Chemistry
Real Chemistry is a global health innovation company committed to making the world a healthier place for all.
Ryvu
Ryvu is a biopharmaceutical company developing small molecule therapies that address clinical limitations of current treatments in oncology.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Schering AG
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
Seqens
Seqens is a integrated in pharmaceutical synthesis and specialty ingredients, delivering unrivalled market responsiveness.
SkyePharma
SkyePharma is a speciality drug delivery company with a range of oral and inhalation technologies.
Synovo GmbH
Synovo GmbH is a drug discovery company with a primary focus on inflammation and innate immune processes
Tebu Bio
Supplying a comprehensive range of innovative and convenient reagents and lab services to European Life Scientists.
UPSA SAS
UPSA SAS specialists in the fight against pain and self-medication.
Vygon (UK)
Vygon is a developer and supplier of medical and surgical disposables company.
Wockhardt Germany GmbH
Wockhardt Germany GmbH is offers prescription drugs for urology and neurology disorders and diabetes.
Yliopiston Apteekki
Yliopiston Apteekki is an online store that offers a wide range of medicine, cosmetics, vitamins and nutritional supplements.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-09-01 | FORMA Therapeutics | FORMA Therapeutics acquired by Novo Nordisk | 1.1 B USD |
| 2021-11-18 | Dicerna Pharmaceuticals | Dicerna Pharmaceuticals acquired by Novo Nordisk | 3.3 B USD |
| 2020-11-06 | Emisphere Technologies | Emisphere Technologies acquired by Novo Nordisk | 1.35 B USD |
| 2020-06-11 | Corvidia | Corvidia acquired by Novo Nordisk | 725 M USD |
| 2018-08-17 | Ziylo | Ziylo acquired by Novo Nordisk | N/A |
| 2015-08-27 | MB2 | MB2 acquired by Novo Nordisk | N/A |
| 2015-08-27 | Calibrium | Calibrium acquired by Novo Nordisk | N/A |
| 2013-05-21 | Xellia Pharmaceuticals | Xellia Pharmaceuticals acquired by Novo Nordisk | 700 M USD |
| 2003-10-01 | Aldaph SpA | Aldaph SpA acquired by Novo Nordisk | N/A |
| 1988-01-01 | ZymoGenetics | ZymoGenetics acquired by Novo Nordisk | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-17 | Beta Bionics | Novo Nordisk investment in Series C - Beta Bionics | 57 M USD |
| 2021-03-16 | Glooko | Novo Nordisk investment in Series D - Glooko | 30 M USD |
| 2020-09-24 | Sundew | Novo Nordisk investment in Seed Round - Sundew | 1.51 M EUR |
| 2016-01-05 | IO Biotech | Novo Nordisk investment in Series A - IO Biotech | 11 M EUR |
| 2015-12-31 | Beta Bionics | Novo Nordisk investment in Series A - Beta Bionics | 5 M USD |
| 2010-04-29 | Affimed | Novo Nordisk investment in Series C - Affimed | 20 M EUR |
| 2008-09-03 | Osprey Pharmaceuticals USA | Novo Nordisk investment in Series A - Osprey Pharmaceuticals USA | 11 M USD |
| 2007-10-25 | Xencor | Novo Nordisk investment in Series E - Xencor | 15 M USD |
| 2004-09-01 | Innate Pharma | Novo Nordisk investment in Series C - Innate Pharma | 15 M EUR |
| 2003-02-07 | TransTech Pharma | Novo Nordisk investment in Venture Round - TransTech Pharma | 24.5 M USD |
Newest Events participated
Official Site Inspections
http://www.novonordisk.com Semrush global rank: 224.79 K Semrush visits lastest month: 324.03 K
- Host name: 52.166.181.85
- IP address: 52.166.181.85
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Novo Nordisk"
Novo Nordisk Canada
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.See details»
Novo Nordisk Org Chart + Executive Team - The Official Board
See the executive team of Novo Nordisk and its org chart, featuring 181 leaders like Lars Jørgensen, Karsten Knudsen and Henrik Wulff . Toggle navigation The Official Board. Search. …See details»
Novo Nordisk - Wikipedia
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, with production facilities in nine countries and affiliates or offices in five. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares. See details»
Novo Nordisk Org Chart Report in 2025 - databahn
Over the years, he held various positions within the organization, gaining invaluable experience and a comprehensive understanding of Novo Nordisk's operations and the pharmaceutical industry as a whole. His dedication, …See details»
Purpose and strategy - Novo Nordisk Annual Report …
At Novo Nordisk, our purpose is clear: driving change to defeat serious chronic diseases.Through our life-changing innovations, we are building a healthier future for generations to come. We are dedicated to reinforcing our leadership in …See details»
Who we are - novonordisk.id
We work in close collaboration with leading universities and biotech companies worldwide to collaborate and speed up new drug discovery. We continuously seek new partners with whom …See details»
Novo Nordisk | driving change to defeat serious …
5 days ago Novo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the local country or region.See details»
en_ca - novonordisk.ca
Local address here Tel: Local telephone number here CVR-no. 24256790See details»
Novo Nordisk Company Profile Revealed: Inside Look
Website: https://www.novonordisk.com Industry Sector : Healthcare - Biotechnology Full Time Employees: 54,393 Annual Revenue: 176.95B (DKK) ... Novo Nordisk Org Chart - Executive Leadership. Novo Nordisk Org Chart - …See details»
Executive Management - Novo Nordisk
Executive remuneration is governed by the applicable Remuneration Policy adopted at the Annual General Meeting, while the Remuneration Principles adopted by the Annual General Meeting in 2019 still governs long term …See details»
Innovation and therapeutic focus - Novo Nordisk Annual Report …
As healthcare innovation accelerates at an unprecedented rate, Novo Nordisk is driving transformative change across multiple therapy areas, with a particular focus on meeting unmet …See details»
Who we are - Novo Nordisk
Our story starts in 1923 when two small Danish companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.. …See details»
Corporate governance - Novo Nordisk
Novo Nordisk’s B shares are listed on Nasdaq Copenhagen and on the New York Stock Exchange (NYSE) as American Depository Receipts (ADRs). Novo Nordisk reports on the …See details»
What we do - Novo Nordisk
Discovering, developing and delivering. For more than 100 years, we have been translating the unmet medical needs of people living with a serious chronic disease into innovative medicines …See details»
CORPORATE GOVERNANCE - novonordisk.com
CORPORATE GOVERNANCE REPORT 2024 Novo Nordisk A/S – Novo Alle 1, 2880 Bagsværd, Denmark – CVR no. 24256790 A Novo Nordisk employee receiving a tour of our active …See details»
About us - Novo Nordisk
Novo Nordisk A/S Novo Alle 1 2880 Bagsværd Denmark +45-4444-8888 CVR-no. 24256790 Our medicines are for the approved indication for which they are authorised in the local country or …See details»
Novo Nordisk a focused healthcare company
Jacob Martin Wiborg Rode +45 3075 5956 [email protected] Sina Meyer +45 3079 6656 [email protected] Ida Schaap Melvold +45 3077 5649 [email protected] Max …See details»
As company struggles, Novo Nordisk CEO Jørgensen to step down …
4 days ago Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — Lars Fruergaard Jørgensen, …See details»
Who we are - Novo Nordisk
Our story starts in 1923 when two small Danish companies started the production of the revolutionary new drug insulin that had just been discovered by two Canadian scientists.. …See details»
Novo Nordisk ousts CEO as Wegovy maker faces growing …
4 days ago The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth transition to new leadership."See details»